← Back to Search

Behavioral Intervention

First Cluster for Racism (TRAnscenDS Trial)

N/A
Recruiting
Led By Corina Lelutiu-Weinberger, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
First, clinic leaders will complete a 15-min Site Characteristics Survey, assessing suitability for participation and clinic comparability for randomization purposes. Staff and leadership at Ryan White clinics will next complete an anonymous 15-minute Eligibility Survey. Clinics will meet initial eligibility if scores are between 4-5 (showing high motivation) on 90% of the items.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 18 months
Awards & highlights

TRAnscenDS Trial Summary

This trial aims to work with HIV/AIDS organizations in the South/East US to create programs that address racism and discrimination against Black, Indigenous, People of Color (BIPOC) living with HIV and

Who is the study for?
This trial is for Ryan White HIV/AIDS Program clinics in the South/East US, focusing on reducing structural racism and discrimination against BIPOC living with HIV and healthcare workers. Clinic leaders must show high motivation to participate, as indicated by specific survey scores.Check my eligibility
What is being tested?
The TRAncenDS intervention is being tested across six selected clinics. It involves interactive trainings aimed at raising awareness and reducing structural racism and discrimination at various levels within the clinic environment over an 18-month period.See study design
What are the potential side effects?
Since this study focuses on training programs rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to discussions about racism and discrimination.

TRAnscenDS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

TRAnscenDS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Structural Racial Discrimination Index (SRD)
Secondary outcome measures
Change in Cultural Humility Score
Change in Modern Racism Scale (MRS) Score
Other outcome measures
Change in Depression, Anxiety and Stress Scale (DASS-21)
Change in Frequency of Perceived Racism and Discrimination
Change in Number of Patients HIV Virally Suppressed
+3 more

TRAnscenDS Trial Design

3Treatment groups
Experimental Treatment
Group I: Third ClusterExperimental Treatment1 Intervention
The intervention will be implemented across three steps with a total of 6 clinics (two clinics per step). The earliest roll-out of the intervention will be at the clinics randomized to Cluster 1. The intervention consists of a mix of Workshops, Interactive Trainings and Learning Circles (virtual and in-person). In the first workshop, the investigators will present baseline findings to all clinic members to 1) raise awareness for the need for intervention to reduce Structural Racism and Discrimination (SRD) , 2) facilitate collaborative processes, 3) catalyze change for practice transformation, to 4) guide the intervention process. This workshop will be followed by a series of interactive trainings covering topics from the history of structural racism, to intersectional stigma and discrimination, bias, systems of accountability, and the creation of a manual to guide the implementation and sustainability of SRD reduction efforts.
Group II: Second ClusterExperimental Treatment1 Intervention
The intervention will be implemented across three steps with a total of 6 clinics (two clinics per step). The earliest roll-out of the intervention will be at the clinics randomized to Cluster 1. The intervention consists of a mix of Workshops, Interactive Trainings and Learning Circles (virtual and in-person). In the first workshop, the investigators will present baseline findings to all clinic members to 1) raise awareness for the need for intervention to reduce Structural Racism and Discrimination (SRD) , 2) facilitate collaborative processes, 3) catalyze change for practice transformation, to 4) guide the intervention process. This workshop will be followed by a series of interactive trainings covering topics from the history of structural racism, to intersectional stigma and discrimination, bias, systems of accountability, and the creation of a manual to guide the implementation and sustainability of SRD reduction efforts.
Group III: First ClusterExperimental Treatment1 Intervention
The intervention will be implemented across three steps with a total of 6 clinics (two clinics per step). The earliest roll-out of the intervention will be at the clinics randomized to Cluster 1. The intervention consists of a mix of Workshops, Interactive Trainings and Learning Circles (virtual and in-person). In the first workshop, the investigators will present baseline findings to all clinic members to 1) raise awareness for the need for intervention to reduce Structural Racism and Discrimination (SRD) , 2) facilitate collaborative processes, 3) catalyze change for practice transformation, to 4) guide the intervention process. This workshop will be followed by a series of interactive trainings covering topics from the history of structural racism, to intersectional stigma and discrimination, bias, systems of accountability, and the creation of a manual to guide the implementation and sustainability of SRD reduction efforts.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,253 Total Patients Enrolled
1 Trials studying Racism
300 Patients Enrolled for Racism
National Institute of Nursing Research (NINR)NIH
580 Previous Clinical Trials
10,376,555 Total Patients Enrolled
Rutgers UniversityOTHER
113 Previous Clinical Trials
2,804,087 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients still being enrolled in this ongoing medical study?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is currently seeking participants. The trial was first posted on March 1st, 2024, and was most recently updated on January 16th, 2024. The study aims to recruit a total of six patients from one designated site."

Answered by AI

What is the current number of individuals being enrolled in this research trial?

"Indeed, the information on clinicaltrials.gov clearly states that this trial is actively seeking eligible patients. The study was initially listed on March 1st, 2024 and was most recently updated on January 16th, 2024. The trial aims to enroll a total of six patients across one location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination
Corina Lelutiu-Weinberger 2024. "Ending the HIV Epidemic With Equity: an Intervention to Reduce the Impact of Racism and Discrimination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05785169.
~4 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top